Finance

Lists
301201:SHE
Chengda Pharmaceuticals Co Ltd
CNÂ¥36.23
+0.03%
(+0.0100) 1D
Sep 2, 3:04:10 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301201...
Open
CNÂ¥36.04
High
CNÂ¥36.50
Low
CNÂ¥35.50
Mkt. cap
5.44B
Avg. vol.
10.60M
Volume
4.30M
Dividend
0.55%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jul 15, 2026
52-wk high
CNÂ¥65.03
52-wk low
CNÂ¥26.38
EPS
-CNÂ¥0.15
Shares outstanding
154.71M
No. of employees
659
Open
CNÂ¥36.04
High
CNÂ¥36.50
Low
CNÂ¥35.50
Mkt. cap
5.44B
Avg. vol.
10.60M
Volume
4.30M
Dividend
0.55%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jul 15, 2026
52-wk high
CNÂ¥65.03
52-wk low
CNÂ¥26.38
EPS
-CNÂ¥0.15
Shares outstanding
154.71M
No. of employees
659
About Chengda Pharmaceuticals Co Ltd
CEO-
Employees659
Founded1980
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
102.64M
121.28M
128.24M
127.25M
Cost of goods sold
52.60M
113.56M
85.75M
90.83M
Cost of revenue
52.60M
113.56M
85.75M
90.83M
Research and development expenses
10.21M
9.90M
11.01M
11.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33.52M
23.17M
24.43M
26.51M
Operating expense
40.48M
37.27M
37.21M
38.03M
Total operating expenses
93.08M
150.83M
122.97M
128.86M
Operating income
9.56M
-29.55M
5.27M
-1.60M
Other non operating income
-1.13M
1.14M
-2.16M
-3.39M
EBT including unusual items
5.04M
-31.24M
9.36M
-7.22M
EBT excluding unusual items
11.76M
-26.99M
2.93M
-4.80M
Income tax expense
1.24M
-2.48M
2.34M
-2.50M
Effective tax rate
24.64%
7.95%
24.99%
34.54%
Other operating expenses
-2.68M
4.07M
237.04K
1.40M
Net income
3.95M
-28.70M
7.00M
-4.70M
Net profit margin
3.85%
-23.66%
5.46%
-3.70%
Earnings per share
-
-
-
-
Interest and investment income
4.09M
3.82M
211.37K
398.90K
Interest expense
-
-2.28M
-398.90K
-211.37K
Net interest expenses
4.09M
1.54M
-187.53K
187.53K
Depreciation and amortization charges
-
-
-
-
EBITDA
21.27M
-11.42M
23.40M
17.22M
Gain or loss from assets sale
37.33K
-37.33K
-
52.48K
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps